0000950123-23-002466.txt : 20230214
0000950123-23-002466.hdr.sgml : 20230214
20230214130405
ACCESSION NUMBER: 0000950123-23-002466
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20221231
FILED AS OF DATE: 20230214
DATE AS OF CHANGE: 20230214
EFFECTIVENESS DATE: 20230214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MPM ASSET MANAGEMENT LLC
CENTRAL INDEX KEY: 0001263048
IRS NUMBER: 043351032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-13379
FILM NUMBER: 23626086
BUSINESS ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001263048
XXXXXXXX
12-31-2022
12-31-2022
false
MPM ASSET MANAGEMENT LLC
399 BOYLSTON STREET, SUITE 1100
BOSTON
MA
02116
13F HOLDINGS REPORT
028-13379
000148467
801-106989
N
Brendan Furey
Chief Compliance Officer
(617) 425-9222
/s/Brendan Furey
Boston
MA
02-14-2023
0
9
239006072
false
INFORMATION TABLE
2
21170.xml
INFORMATION TABLE FOR FORM 13F
Amryt Pharma plc
Common
03217L106
19482554
2668843
SH
SOLE
2668843
0
0
Dyne Therapeutics, Inc.
Common
26818M108
57385602
4951303
SH
SOLE
4951303
0
0
Entrada Therapeutics, Inc.
Common
29384C108
59836600
4425784
SH
SOLE
4425784
0
0
Harpoon Therapeutics, Inc.
Common
41358P106
2273388
3131388
SH
SOLE
3131388
0
0
iTeos Therapeutics, Inc.
Common
46565G104
53488471
2738785
SH
SOLE
2738785
0
0
Oncorus, Inc.
Common
68236R103
720914
2849464
SH
SOLE
2849464
0
0
Repare Therapeutics, Inc.
Common
760273102
32989176
2242636
SH
SOLE
2242636
0
0
TCR2 Therapeutics, Inc.
Common
87808K106
4046814
4050865
SH
SOLE
4050865
0
0
Werewolf Therapeutics, Inc.
Common
95075A107
8782553
4284172
SH
SOLE
4284172
0
0